MPM Asset Management’s Repare Therapeutics RPTX Stock Holding History

MPM Asset Management’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.97M	Hold	1,121,318	–	–	4.43%	4
2025 Q2	$1.56M	Hold	1,121,318	–	–	3.6%	4
2025 Q1	$1.11M	Sell	1,121,318 -562,389	-33%	-$678K	1.59%	5
2024 Q4	$2.21M	Sell	1,683,707 -558,929	-25%	-$1.66M	1.77%	6
2024 Q3	$7.71M	Hold	2,242,636	–	–	5.31%	5
2024 Q2	$7.4M	Hold	2,242,636	–	–	4.06%	5
2024 Q1	$10.6M	Hold	2,242,636	–	–	4.31%	5
2023 Q4	$16.4M	Hold	2,242,636	–	–	8.04%	5
2023 Q3	$27.1M	Hold	2,242,636	–	–	14.51%	4
2023 Q2	$23.7M	Hold	2,242,636	–	–	11.64%	4
2023 Q1	$22.1M	Hold	2,242,636	–	–	9.2%	5
2022 Q4	$33M	Hold	2,242,636	–	–	13.8%	4
2022 Q3	$27.2M	Hold	2,242,636	–	–	10.36%	4
2022 Q2	$31.4M	Hold	2,242,636	–	–	13.24%	4
2022 Q1	$31.9M	Hold	2,242,636	–	–	10.92%	4
2021 Q4	$47.3M	Hold	2,242,636	–	–	10.22%	5
2021 Q3	$58.8M	Sell	2,242,636 -28,541	-1%	-$922K	13.64%	4
2021 Q2	$70.8M	Sell	2,271,177 -331,912	-13%	-$10.9M	13.17%	4
2021 Q1	$79.9M	Sell	2,603,089 -400,683	-13%	-$13.6M	15.43%	3
2020 Q4	$103M	Hold	3,003,772	–	–	14.58%	4
2020 Q3	$92.4M	Hold	3,003,772	–	–	17.24%	2
2020 Q2	$93.2M	Buy	+3,003,772	New	+$96.4M	27.72%	1

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MPM Asset Management's RPTX Position: Q3 2025 in Review

MPM Asset Management held its Repare Therapeutics (RPTX) position steady in Q3 2025 at 1,121,318 shares worth $1.97M. The position accounts for 4.43% of the portfolio, ranked #4.

MPM Asset Management first reported a position in RPTX in Q2 2020 and has held it in 22 quarters since. The position peaked at $103M in Q4 2020. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.

MPM Asset Management held 1,121,318 shares of Repare Therapeutics worth $1.97M as of Q3 2025.
MPM Asset Management left its Repare Therapeutics share count unchanged in Q3 2025.
Repare Therapeutics made up 4.43% of MPM Asset Management's portfolio in Q3 2025, its #4 holding.
MPM Asset Management first reported a position in Repare Therapeutics in Q2 2020 and has held it in 22 quarters since.
MPM Asset Management's Repare Therapeutics position peaked at $103M in Q4 2020.
45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.

Based on MPM Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.